Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 Azacytosine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Novel high-pressure formate method for 5-azacytosine improves yield above 70% and purity exceeding 98%, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN111377986B details a novel purification method for decitabine intermediate II, removing critical impurities to enhance beta-configuration yield and supply reliability.